Extension of Approval for Stelara® (Ustekinumab) for the Treatment of Ulcerative colitis

被引：0
|
作者：
机构：
来源：
VISCERAL MEDICINE | 2019年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：399 / 399
页数：1
相关论文
共 50 条
  • [11] Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic Review
    Gisbert, Javier P.
    Parody-Rua, Elizabeth
    Chaparro, Maria
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (02) : 292 - 302
  • [12] Ustekinumab as rescue treatment in therapy-refractory or -intolerant ulcerative colitis
    Ochsenkuehn, T.
    Janelidze, S.
    Tillack, C.
    Beigel, F.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S495 - S495
  • [13] Extension of ulcerative colitis
    Alkim, Canan
    Alkim, Huseyin
    Dagli, Ulku
    Parlak, Erkan
    Ulker, Aysel
    Sahin, Burhan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2011, 22 (04): : 382 - 387
  • [14] A Stellar Case of Stelara in the Treatment of Lymphocytic Colitis
    Abughazaleh, Shaadi
    Glassner, Kerri
    Wilhite, Amanda
    Abraham, Bincy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S1154 - S1154
  • [15] Identifying the Optimal Treatment Sequence for Ustekinumab in Treatment Algorithms for Advanced Therapies in Ulcerative Colitis
    Zhang, Suyuan
    Dimova, Mariya
    Teeple, Amanda
    Ding, Zhijie
    Muser, Erik
    Izanec, James L.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S338 - S338
  • [16] Tacrolimus plus ustekinumab in refractory ulcerative colitis
    Cortes, Irene Latras
    Sierra-Ausin, Monica
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (02): : 148 - 149
  • [17] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis
    Chang, Hui-Chin
    Gau, Shuo-Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1242 - 1242
  • [18] Ustekinumab as an opportunity for refractory Ulcerative Colitis patients
    Iborra, M.
    Soutullo, C.
    Gimeno, M.
    Bastida, G.
    Aguas, M.
    Cerrillo, E.
    Saez-Gonzalez, E.
    Garrido, A.
    Minguez, A.
    Bordetas, J.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I383 - I384
  • [19] Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis
    Sands, B. E.
    Sandborn, W. J.
    Panaccione, R.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Adedokun, O. J.
    Li, K.
    Peyrin-Biroulet, L.
    Van Assche, G.
    Danese, S.
    Targan, S.
    Abreu, M. T.
    Hisamatsu, T.
    Szapary, P.
    Marano, C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1201 - 1214
  • [20] Ustekinumab as an opportunity for refractory Ulcerative Colitis patients
    Iborra, M.
    Soutullo, C.
    Gimeno, M.
    Bastida, G.
    Aguas, M.
    Cerrillo, E.
    Saez-Gonzalez, E.
    Garrido, A.
    Minguez, A.
    Bordetas, J.
    Nos, P.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I383 - I384
12345